Article Information
- Received September 18, 2003
- Revision received December 15, 2003
- Accepted December 15, 2003
- First published February 11, 2004.
- Version of record published February 11, 2004.
Author Information
- Shigeki Tsutsui1,
- Jurgen Schnermann3,
- Farshid Noorbakhsh1,
- Scot Henry1,
- V. Wee Yong1,
- Brent W. Winston2,
- Kenneth Warren4, and
- Christopher Power1
- Departments of 1Clinical Neurosciences and 2 Critical Care Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada, 3National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1370, and 4Department of Medicine, University of Alberta, Edmonton, Alberta T6G 2B7, Canada
Author contributions
Disclosures
- Received September 18, 2003.
- Revision received December 15, 2003.
- Accepted December 15, 2003.
S.T. is a Multiple Sclerosis Society of Canada (MSSC) Fellow, V.W.Y. is an Alberta Heritage Foundation for Medical Research (AHFMR) Senior Scholar/Canadian Institutes of Health Research (CIHR) Scientist, B.W.W. is an AHFMR Clinical Investigator, and C.P. is an AHFMR Scholar/CIHR Investigator. These studies were supported by the MSSC and CIHR-Interdisciplinary Health Research Team. We thank Ken Jacobson and Dominic Corkill for helpful discussions; Andrea Sullivan, Connie Mowat, and Claudia Silva for technical assistance; and Belinda Ibrahim for manuscript preparation.
Correspondence should be addressed to Dr. Christopher Power, Neuroscience Research Group, Department of Clinical Neurosciences, University of Calgary, Heritage Medical Research Building, Room 150, 3330 Hospital Drive Northwest, Calgary, AB T2N 4N1, Canada. E-mail: power{at}ucalgary.ca.
Copyright © 2004 Society for Neuroscience 0270-6474/04/241521-09$15.00/0
Online Impact